key: cord-0717252-mz8uk0ev
authors: Vélez, Christopher; Paz, Mary; Silvernale, Casey; Stratton, Lawrence W.; Kuo, Braden; Staller, Kyle; Barreto, Esteban; Cobos, Josselyn Vergara; Buchanan, Kelly L.; Desai, Anshuman C.; Chablaney, Shreya; López, Ingrid Guerrero; Betancourt, Joseph R.
title: Factors associated with chronic de novo post-COVID gastrointestinal disorders in a metropolitan United States county
date: 2021-10-21
journal: Clin Gastroenterol Hepatol
DOI: 10.1016/j.cgh.2021.10.020
sha: 0e16d8b8fff16509e58c8df79808e20ea85b73c5
doc_id: 717252
cord_uid: mz8uk0ev

The first coronavirus disease 2019 (COVID-19) pandemic surge harshly impacted the medically underserved populations of the urbanized northeastern United States. Severe acute respiratory syndrome coronavirus 2 virions infect the gastrointestinal (GI) tract, and GI symptoms are common during acute infection.1 Post-COVID syndromes increasingly are recognized as important public health considerations.2 Postinfectious disorders of gut-brain interaction (DGBIs; formerly known as functional gastrointestinal disorders) can occur after enteric illness; the COVID-19 pandemic is anticipated to provoke DGBI development3 within a rapidly evolving post-COVID framework of illness. Here, we evaluate factors associated with DGBI-like post-COVID gastrointestinal disorders (PCGIDs) in our hospital's surrounding communities comprised predominantly of racial/ethnic minorities and those of reduced socioeconomic status.

The first COVID-19 pandemic surge impacted harshly the medically underserved populations of the urbanized northeastern United States. SARS-CoV-2 virions infect the gastrointestinal (GI) tract and GI symptoms are common during acute infection [1] . Post- COVID syndromes are increasingly recognized as important public health considerations [2] . Post-infectious disorders of gut-brain interaction (DGBIs, formerly "functional gastrointestinal disorders") can occur after enteric illness; the COVID-19 pandemic is anticipated to provoke DGBI-development [3] within a rapidly evolving "post-COVID" framework of illness. Here, we evaluate factors associated with DGBI-like "post-COVID gastrointestinal disorders" (PCGIDs) in our hospital's surrounding communities comprised predominantly of racial/ethnic minorities and those of reduced socioeconomic status.

A longitudinal cohort study was performed of ambulatory patients retrospectively identified as being COVID-19 infected from April through September 2020. Potential participants were mailed a brochure prior to initial screening phone calls (in English and Spanish as well offered a cash raffle incentive for participation). Screening phone calls occurred 6-months after diagnosis at our hospital's respiratory illness clinics, examining for PCGIDs. Subjects were asked to recall if they suffered from dyspeptic or bowel symptoms prior to COVID-19 infection; despite the inherent limitation, this decision was taken to reduce data loss given uneven patient contact with our hospital prior to COVID-19 diagnosis. Eligibility criteria included protocolized gastrointestinal symptom assessment at COVID-19 diagnosis, speaking English or Spanish, participation in phone screening, and capability of providing consent. Patients with organic/structural conditions explaining dyspeptic and bowel symptoms were excluded as well (Supplement Methods).

Our primary outcome was incident FD-like and IBS-like PCGIDs present for at least 3months, 6-months after COVID-19 diagnosis using modified Rome IV questions (when answering "yes" to recurrent complaints of 1 or more of 4 dyspepsia symptoms, and "yes" to recurrent complaints of at least 2 of 3 bowel complaints, "modified" as chronic GI symptoms needed not be present for 6-months or more) in those reporting an absence of FD-like and IBS-like symptoms pre-COVID. Secondary outcomes in patients meeting PCGID criteria were GI symptom and psychological distress scores on patient reported J o u r n a l P r e -p r o o f outcome measures (PROMs, Supplemental methods) including versions validated in Spanish [4] [5] [6] [7] [8] . Socioeconomic disadvantage was estimated using patient zip codes as previously described [9] .

We used univariable and multivariable methods to determine factors associated with incident chronic FD-or IBS-like post-COVID symptoms with the latter controlling for confounders by logistic regression adjusted for age, race/ethnicity, sex, history of depression/anxiety, GI symptoms at COVID-19 diagnosis, subsequent hospitalization due to COVID-19 infection after ambulatory diagnosis, pandemic-related income losses, or perceived pandemic-related personal distress. We also evaluated the relationship between GI symptom severity and anxiety/depression using Pearson correlation. Unsurprisingly given the demographics in our metropolitan county, we evaluated a cohort comprised primarily of Latino/a patients residing in disfavored locales. In ambulatory J o u r n a l P r e -p r o o f COVID-19 patients, we demonstrate a heavy burden (39.5%) of de novo PCGIDs in this predominantly medically underserved community. Our results represent some of the earliest data suggesting that FD-and IBS-like PCGIDs are of clinical concern. While the provoking event is presumed to be viral infection of the digestive tract, the independent association of sex and anxiety/depression with risk of developing post-COVID GI symptoms is similar to what has been reported in DGBIs. As neuropsychiatric complications occur post-COVID [10] , the association with anxiety/depression becomes even more critical given the correlation we note here between increased psychological distress and GI symptom severity. That chronic dyspepsia and bowel symptoms were as likely to occur in patients with GI symptoms during COVID-19 diagnosis as those without GI symptoms warrants further investigation. It is anticipated in some that FD-and IBSlike PCGIDs will progress to meet formal time-based Rome criteria; our work suggests providers need to be mindful of possible DGBI-development as post-COVID syndromes.

We acknowledge several limitations to this work, including a relatively small cohort, potential recall bias related to pre-COVID GI symptoms, and possible selection bias both in term of those who could not be reached by phone and those willing to complete phone We assembled in retrospective fashion a cohort of patients diagnosed with COVID-19 who underwent protocolized GI symptom screening during ambulatory testing at respiratory illness clinics (RICs) during the first surge of the COVID-19 pandemic from April-September 2020. We targeted such patients as they had clear assessment for the presence or absence of GI symptoms during COVID-19 infection using a standardized form developed at our institution in the electronic medical record (Epic Systems Corporation). Patients who did not undergo systematic assessment for absence or presence of GI symptoms were not included. Prior COVID-19 GI symptom studies have been limited by predominantly recruiting hospitalized patients; we targeted a cohort of patients diagnosed in the ambulatory setting who are more likely to reflect a more typical illness course during and after COVID-19 infection versus those admitted with severe disease.

Our county is highly urbanized and includes an increased percentage of communities-ofcolor and greater poverty rates relative to our state (Supplemental Table 1 ). Preferred language was obtained from the electronic medical record for the purposes of determining language of screening phone calls and mailed brochures. Screening surveys were administered prospectively 6-months after COVID-19 diagnosis, although patients were asked retrospectively about the presence or absence of dyspeptic or bowel symptoms prior to COVID-19 infection. While 272 patients completed the survey, 72 retrospectively reported FD-like and IBS-like symptoms prior to infection (Supplemental Figure 1) . The 4 patients who were excluded due to organic illness had diagnoses of Helicobacter pylori, pancreatitis, and pregnancy (which were felt to be better explanations for gastrointestinal distress).

Rome IV-styled questions consisted of the following prompts for dyspepsia including versions generated in Spanish: (1) bothersome fullness in your stomach after eating; (2) getting full too quickly when you eat; (3) bothersome upper abdominal or stomach painabove the belly button; (4) bothersome upper abdominal or stomach burningabove the belly button. Patients were deemed to have FD-like symptoms if they answered "yes" to any of these 4 dyspepsia-related questions (either prior to COVID-19 or after COVID-19 infection). Similarly, Rome IV-styled questions consisted of the following prompts for bowel disturbance: (1) recurrent/repeated abdominal or stomach pain related to bowel movements (when "pooping") which gets better or gets worse with bowel movements; (2) recurrent/repeated abdominal or stomach pain associated with change in stool frequency (bowel movements occurring more often or less often); (3) recurrent/repeated abdominal pain associated with a change in the way stool looks. If patients stated the presence of at least 2 of these 3, they were determined to have IBS-like symptoms (either prior to COVID-19 or after COVID-19 infection).

Patient reported outcome measures employed in patients who had FD-like and IBS-like complaints included (1) "Patient Assessment of Gastrointestinal Disorders -Symptom Severity" (PAGI-SYM) score for those with incident functional dyspepsia; (2) the "Irritable

Covid-19 and the digestive system

Managing the Inevitable Surge of Post-COVID-19 Functional Gastrointestinal Disorders

Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders

The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

Short screening scales to monitor population prevalences and trends in nonspecific psychological distress

Traducción, adaptación cultural y validación al español del cuestionario de gravedad del síndrome de intestino irritable (Irritable Bowel Syndrome Severity Score). Revista Española de Enfermedades Digestivas

Estudio preliminar de validez y confiabilidad del cuestionario PAGI-SYM para determinar síntomas de dispepsia acorde con la calidad de vida. Revista Colombiana de Gastroenterología

Lower socioeconomic status is associated with an increased prevalence of comorbid anxiety and depression among patients with irritable bowel syndrome: results from a multicenter cohort

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors

IBS-SSS) for those with incident IBS; and (3) the "Kessler Psychological Distress Scale" (K10). These are patient reported outcome measures (PROMs) well established in the study of patients with disordered gut brain interaction